CN101897711B - 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 - Google Patents
含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 Download PDFInfo
- Publication number
- CN101897711B CN101897711B CN200910086274.6A CN200910086274A CN101897711B CN 101897711 B CN101897711 B CN 101897711B CN 200910086274 A CN200910086274 A CN 200910086274A CN 101897711 B CN101897711 B CN 101897711B
- Authority
- CN
- China
- Prior art keywords
- aspirin
- pharmaceutical composition
- folic acid
- atorvastatin
- nicotinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
复方种类 | 阿托伐他汀 | 阿司匹林 | 叶酸 | 亚叶酸钙 | 左旋亚叶酸钙 | 烟酸 |
1 | 10mg | 50mg | 0.2mg | - | - | 400mg |
2 | 10mg | 100mg | 0.8mg | - | - | 100mg |
3 | 80mg | 150mg | 1.6mg | - | - | 200mg |
4 | 10mg | 50mg | 0.4mg | - | - | 300mg |
5 | 80mg | 100mg | - | 0.5mg | - | 400mg |
6 | 10mg | 100mg | - | 1.0mg | - | 100mg |
7 | 40mg | 150mg | - | - | 0.125mg | 200mg |
8 | 10mg | 100mg | - | - | 0.25mg | 300mg |
9 | 20mg | 50mg | 0.8mg | - | - | 50mg |
10 | 10mg | 100mg | 0.6mg | - | - | 100mg |
11 | 20mg | 100mg | - | 1.0mg | - | 200mg |
12 | 10mg | 100mg | - | 0.5mg | - | 300mg |
13 | 20mg | 150mg | - | - | 0.75mg | 100mg |
14 | 10mg | 100mg | - | - | 0.25mg | 200mg |
15 | 10mg | 100mg | - | - | 0.125mg | 300mg |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910086274.6A CN101897711B (zh) | 2009-05-27 | 2009-05-27 | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910086274.6A CN101897711B (zh) | 2009-05-27 | 2009-05-27 | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101897711A CN101897711A (zh) | 2010-12-01 |
CN101897711B true CN101897711B (zh) | 2014-08-13 |
Family
ID=43223854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910086274.6A Active CN101897711B (zh) | 2009-05-27 | 2009-05-27 | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101897711B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2754134C (en) * | 2009-02-11 | 2018-09-18 | Cadila Pharmaceuticals Ltd. | Stable pharmaceutical composition for atherosclerosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785196A (zh) * | 2004-12-10 | 2006-06-14 | 张鹏 | 一种防治心脑血管疾病的复合制剂 |
CN1891219A (zh) * | 2005-07-07 | 2007-01-10 | 安徽省现代中药研究中心 | 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物 |
-
2009
- 2009-05-27 CN CN200910086274.6A patent/CN101897711B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785196A (zh) * | 2004-12-10 | 2006-06-14 | 张鹏 | 一种防治心脑血管疾病的复合制剂 |
CN1891219A (zh) * | 2005-07-07 | 2007-01-10 | 安徽省现代中药研究中心 | 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101897711A (zh) | 2010-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100955669B1 (ko) | HMGCoA 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법 | |
CN101069745B (zh) | 治疗2型糖尿病的药物组合物 | |
CN102480954A (zh) | 用于动脉粥样硬化的稳定的药物组合物 | |
CN101897706A (zh) | 含有叶酸和b族维生素的组合物及其用途 | |
CN103721261B (zh) | 含有sglt2抑制剂和b族维生素的药物组合物及其用途 | |
CN100502870C (zh) | 含有瑞舒伐他汀或匹伐他汀和b族维生素的药物组合物 | |
CN103230592A (zh) | 他汀类药物与5-甲基四氢叶酸的组合物及其用途 | |
CN101590052A (zh) | 含有钙离子拮抗剂、他汀类降脂药和烟酸的药物组合物及其用途 | |
CN101897711B (zh) | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸、烟酸的药物组合物及其用途 | |
CN106310278A (zh) | 一种含叶酸的多联降压药物组合物 | |
CN101590051B (zh) | 含有烟酸、HMG-CoA还原酶抑制剂和α-糖苷酶抑制剂的药物组合物 | |
CN101069746B (zh) | 含有降糖药物和抗血小板药物的组合物 | |
CN101590084B (zh) | 含有血管紧张素转化酶抑制剂、b族维生素和银杏叶提取物的药物组合物 | |
CN101897710A (zh) | 含有HMG-CoA还原酶抑制剂、阿司匹林、叶酸的药物组合物及其用途 | |
CN101590239B (zh) | 含有利尿剂、他汀和叶酸的药物组合物及其用途 | |
CN103230594A (zh) | α-葡萄糖苷酶抑制剂和B族维生素的药物组合物 | |
CN101590240B (zh) | 含血管紧张素ⅱ受体拮抗剂、他汀和叶酸的组合物及用途 | |
CN106310273A (zh) | 一种四联降压药物组合物 | |
KR20170012169A (ko) | 경구용 복합제제 | |
CN1969855B (zh) | 一种具有靶器官保护作用的药物组合物及其用途 | |
CN100531729C (zh) | 含有苯氧芳酸类药物和牛磺酸的组合物 | |
CN101590040A (zh) | 含有吲哒帕胺和b族维生素的组合物及其用途 | |
CN101590232A (zh) | 血管紧张素转化酶抑制剂、他汀类降脂药和烟酸的药物组合物及其用途 | |
CN1891296B (zh) | 含有钙拮抗剂和苯氧酸类化合物的药物组合物 | |
CN102349906B (zh) | 阿托伐他汀钙和烟酸组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN AUSA PHARMED LTD. Free format text: FORMER OWNER: BEIJING AOSA MEDICINE RESEARCH CENTRE CO., LTD. Effective date: 20141028 Free format text: FORMER OWNER: SHENZHEN AOSA MEDICINE CO., LTD.;ANHUI BIOLOGICAL MEDICAL INSTITUTE Effective date: 20141028 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100037 XICHENG, BEIJING TO: 518057 SHENZHEN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141028 Address after: 518057, No. 16, No. three, No. 3, building No. 1, No. 1, building No. 1, building No. 1, No. 1, building, high tech, Nanshan hi tech Zone, Shenzhen, Guangdong Patentee after: Shenzhen Osa Pharmaceutical Co.,Ltd. Address before: 100037 Beijing City, Xicheng District Fuwai Street No. 11 building 810 room Guobin Patentee before: Beijng Aosa Medical Research Center, Inc. Patentee before: SHENZHEN AUSA PHARMED Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230616 Address after: 518057 the 1st and 2nd floors of Building 2, phase III of biological incubator, No.16, Gaoxin Zhongyi Road, central high tech Zone, Nanshan District, Shenzhen City, Guangdong Province; the east side of the 1st floor and the 2nd and 3rd floors of building 3 Patentee after: SHENZHEN AUSA PHARMACEUTICAL Co.,Ltd. Patentee after: Shenzhen Osa Pharmaceutical Co.,Ltd. Patentee after: SHENZHEN AUSA PHARMED Co.,Ltd. Address before: 518057 the west side of the first floor, building 3, phase III, biological incubator, No.16, Gaoxin Zhongyi Road, Nanshan High tech Zone, Shenzhen City, Guangdong Province Patentee before: Shenzhen Osa Pharmaceutical Co.,Ltd. |